Atia Vision, a Shifamed portfolio company committed to improving patient outcomes through the development of a modular presbyopia-correcting intraocular lens, today announced the initial closing of its $20M Series D commitment to preferred stock financing. Financing was led by Cormorant Asset Management, with the participation of The Capital Partnership (TCP), AMED Ventures and Shangbay Capital. The funding will be used to advance Atia Vision’s clinical efforts.
“We are very pleased to conclude this latest round of financing with strong, continued support from our investors,” said Mariam Maghribi, President and CEO of Atia Vision. “We look forward to furthering our clinical studies and demonstrating the performance of our technology, which aims to restore the full range of functional vision for patients with cataracts and presbyopia. “That’s right.
Almost 67 million people worldwide are visually impaired due to cataracts, which can lead to blindness if untreated. 1 Atia Vision’s innovation addresses the unmet needs of patients with cataracts and presbyopia through a familiar conventional cataract procedure. Atia Vision’s modular intraocular lens technology features an accommodating base responsive to ciliary muscles, simulating the natural mechanism of the eye and a fixed lens element that allows for subsequent refractive correction.
“Atia Vision’s proprietary technology represents an elegant advancement that uniquely addresses the clinical challenges currently facing visual impairment space, of which cataracts and presbyopia are the largest segments,” said Bihua Chen, Cormorant Asset Management Founder and CEO. “We are proud to further strengthen our partnership with Atia Vision and look forward to delivering this next generation solution to the ophthalmology market. “That’s right.
On Atia Vision, Inc.
Atia Vision is a privately owned medical device company formed by Shifamed LLC, Silicon Valley’s medical innovation hub. Please visit www to learn more about Atia Vision. Atiavision’s Come on,
About LLC Shifamed
Founded by serial entrepreneur Amr Salahieh, Shifamed LLC is a highly specialized medical innovation hub focused on developing advanced solutions that accelerate time on the market, reduce risk, increase impact and forge a path to a world where patients can lead longer, healthier lives. Please visit www to learn more about Shifamed. Shaifamed Come on,
Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/Atia%20Vision/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co
